BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35487075)

  • 1. The pneumonia severity index: Assessment and comparison to popular machine learning classifiers.
    Wang D; Willis DR; Yih Y
    Int J Med Inform; 2022 Jul; 163():104778. PubMed ID: 35487075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine-Learning Model for Mortality Prediction in Patients With Community-Acquired Pneumonia: Development and Validation Study.
    Cilloniz C; Ward L; Mogensen ML; Pericàs JM; Méndez R; Gabarrús A; Ferrer M; Garcia-Vidal C; Menendez R; Torres A
    Chest; 2023 Jan; 163(1):77-88. PubMed ID: 35850287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study.
    Dai W; Ke PF; Li ZZ; Zhuang QZ; Huang W; Wang Y; Xiong Y; Huang XZ
    J Med Internet Res; 2021 Feb; 23(2):e23390. PubMed ID: 33534722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
    Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
    Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia.
    Bradley J; Sbaih N; Chandler TR; Furmanek S; Ramirez JA; Cavallazzi R
    Chest; 2022 Apr; 161(4):927-936. PubMed ID: 34740594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].
    Chen Y; Li C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized Mortality Prediction for Community-acquired Pneumonia at 117 Veterans Affairs Medical Centers.
    Jones BE; Ying J; Nevers M; Alba PR; He T; Patterson OV; Jones MM; Stevens V; Shen J; Humpherys J; Peterson KS; Rutter ED; Gundlapalli AV; Weir CR; Dean NC; Fine MJ; Samore MC; Greene TH
    Ann Am Thorac Soc; 2021 Jul; 18(7):1175-1184. PubMed ID: 33635750
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia.
    Christ-Crain M; Breidthardt T; Stolz D; Zobrist K; Bingisser R; Miedinger D; Leuppi J; Tamm M; Mueller B; Mueller C
    J Intern Med; 2008 Aug; 264(2):166-76. PubMed ID: 18298480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
    Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
    Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.
    Legramante JM; Mastropasqua M; Susi B; Porzio O; Mazza M; Miranda Agrippino G; D Agostini C; Brandi A; Giovagnoli G; Di Lecce VN; Bernardini S; Minieri M
    PLoS One; 2017; 12(11):e0187702. PubMed ID: 29161297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
    Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B
    Crit Care; 2006; 10(3):R96. PubMed ID: 16805922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-Lymphocyte Ratio Improves the Accuracy and Sensitivity of Pneumonia Severity Index in Predicting 30-Day Mortality of CAP Patients.
    Zhang HF; Ge YL; Wang HY; Zhang Q; Li WQ; Chen Y; Chen QC; Jin JJ; Xu J; Zhang S; Xu TT; Zhang X; Yu HL; Zhu XY; Liu CH; Bai J; Zhang JB; Xie BQ; Wang Y; Fu AS; Zhang PP
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of blood parameters for community-acquired pneumonia.
    Huang Y; Liu A; Liang L; Jiang J; Luo H; Deng W; Lin G; Wu M; Li T; Jiang Y
    Int Immunopharmacol; 2018 Nov; 64():10-15. PubMed ID: 30144639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia.
    Schuetz P; Stolz D; Mueller B; Morgenthaler NG; Struck J; Mueller C; Bingisser R; Tamm M; Christ-Crain M
    BMC Infect Dis; 2008 Feb; 8():22. PubMed ID: 18304365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective Study of Presepsin as an Indicator of the Severity of Community-Acquired Pneumonia in Emergency Departments: Comparison with Pneumonia Severity Index and CURB-65 Scores.
    Ham JY; Song KE
    Lab Med; 2019 Oct; 50(4):364-369. PubMed ID: 30892617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of severity scores for home care-based patients suffering from pneumonia.
    Ishibashi F; Sunohara M; Kawagoe S
    Geriatr Gerontol Int; 2015 Mar; 15(3):311-7. PubMed ID: 24617550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
    Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
    PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.
    Yandiola PPE; Capelastegui A; Quintana J; Diez R; Gorordo I; Bilbao A; Zalacain R; Menendez R; Torres A
    Chest; 2009 Jun; 135(6):1572-1579. PubMed ID: 19141524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia.
    Fine MJ; Hanusa BH; Lave JR; Singer DE; Stone RA; Weissfeld LA; Coley CM; Marrie TJ; Kapoor WN
    J Gen Intern Med; 1995 Jul; 10(7):359-68. PubMed ID: 7472683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS.
    Richards G; Levy H; Laterre PF; Feldman C; Woodward B; Bates BM; Qualy RL
    J Intensive Care Med; 2011; 26(1):34-40. PubMed ID: 21341394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.